Literature DB >> 10217737

Symplostatin 2: a dolastatin 13 analogue from the marine cyanobacterium Symploca hydnoides.

G G Harrigan1, H Luesch, W Y Yoshida, R E Moore, D G Nagle, V J Paul.   

Abstract

An analogue of dolastatin 13 (2) has been isolated from a marine cyanobacterium, Symploca hydnoides, collected near Guam. This new cyclic depsipeptide contains a L-methionine sulfoxide residue; however, the sulfoxide exists as both R- and S-forms, resulting in the doubling of several signals in the 1H and 13C NMR spectra. Structure elucidation required extensive application of 2-D NMR techniques such as COSY, HMQC, HMBC, and ROESY. The trivial name symplostatin 2 (1) has been assigned to the new metabolite and its isolation from S. hydnoides further supports the proposal that many compounds originally isolated from the sea hare Dolabella auricularia are most probably of cyanobacterial origin.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10217737     DOI: 10.1021/np980553b

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  13 in total

Review 1.  Search and discovery strategies for biotechnology: the paradigm shift.

Authors:  A T Bull; A C Ward; M Goodfellow
Journal:  Microbiol Mol Biol Rev       Date:  2000-09       Impact factor: 11.056

2.  Symplocamide A, a potent cytotoxin and chymotrypsin inhibitor from the marine Cyanobacterium Symploca sp.

Authors:  Roger G Linington; Daniel J Edwards; Cynthia F Shuman; Kerry L McPhail; Teatulohi Matainaho; William H Gerwick
Journal:  J Nat Prod       Date:  2007-12-29       Impact factor: 4.050

Review 3.  Marine natural product peptides with therapeutic potential: Chemistry, biosynthesis, and pharmacology.

Authors:  Vedanjali Gogineni; Mark T Hamann
Journal:  Biochim Biophys Acta Gen Subj       Date:  2017-08-24       Impact factor: 3.770

4.  Tutuilamides A-C: Vinyl-Chloride-Containing Cyclodepsipeptides from Marine Cyanobacteria with Potent Elastase Inhibitory Properties.

Authors:  Lena Keller; Kirley Marques Canuto; Chenxi Liu; Brian M Suzuki; Jehad Almaliti; Asfandyar Sikandar; C Benjamin Naman; Evgenia Glukhov; Danmeng Luo; Brendan M Duggan; Hendrik Luesch; Jesko Koehnke; Anthony J O'Donoghue; William H Gerwick
Journal:  ACS Chem Biol       Date:  2020-01-28       Impact factor: 5.100

5.  Penilumamide, a novel lumazine peptide isolated from the marine-derived fungus, Penicillium sp. CNL-338.

Authors:  Sven W Meyer; Thorsten F Mordhorst; Choonghwan Lee; Paul R Jensen; William Fenical; Matthias Köck
Journal:  Org Biomol Chem       Date:  2010-03-11       Impact factor: 3.876

6.  Depsipeptides from a Guamanian Marine Cyanobacterium, Lyngbya bouillonii, with Selective Inhibition of Serine Proteases.

Authors:  Brent K Rubio; Stephen M Parrish; Wesley Yoshida; Peter J Schupp; Tom Schils; Philip G Williams
Journal:  Tetrahedron Lett       Date:  2010-12-22       Impact factor: 2.415

7.  Halogenated cyclic peptides isolated from the sponge Corticium sp.

Authors:  Damian W Laird; Daniel V LaBarbera; Xidong Feng; Tim S Bugni; Mary Kay Harper; Chris M Ireland
Journal:  J Nat Prod       Date:  2007-03-29       Impact factor: 4.050

8.  Tiglicamides A-C, cyclodepsipeptides from the marine cyanobacterium Lyngbya confervoides.

Authors:  Susan Matthew; Valerie J Paul; Hendrik Luesch
Journal:  Phytochemistry       Date:  2009-10-06       Impact factor: 4.072

9.  Morphological, chemical, and genetic diversity of tropical marine cyanobacteria Lyngbya spp. and Symploca spp. (Oscillatoriales).

Authors:  Robert W Thacker; Valerie J Paul
Journal:  Appl Environ Microbiol       Date:  2004-06       Impact factor: 4.792

10.  Dolastatin 15 from a Marine Cyanobacterium Suppresses HIF-1α Mediated Cancer Cell Viability and Vascularization.

Authors:  Ranjala Ratnayake; Sarath P Gunasekera; Jia Jia Ma; Long H Dang; Thomas J Carney; Valerie J Paul; Hendrik Luesch
Journal:  Chembiochem       Date:  2020-05-12       Impact factor: 3.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.